Student Publications

Twenty-three peer-reviewed publications and counting. We even made a cover page!

1. Huang B et al. A Biomarker Cluster for Polycystic Kidney Disease: Correlation with Cystic Index. Recent Patents on Biomarkers 5:35-43, 2015.

2. Huang B et al. Acute Injury in Natural Diet-Induced Fatty Livers - A Model for Therapy Development. Recent Patents on Biomarkers 5:101-107, 2015.

3. Narayan P et al. Late intervention with the small molecule BB3 mitigates postischemic kidney injury. Am J Physiol 311:F352-61 2016.

4. Nieto JA et al. An Empirical Biomarker-based Calculator for Autosomal Recessive Polycystic Kidney Disease - The Nieto-Narayan Formula. PlosOne., 2016.

5. Paka L et al. Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease. World J Gastroenterol 23:4181-4190, 2017.

6. Nieto JA et al. A modified elliptical formula to estimate kidney collagen content in a model of chronic kidney disease. PLoS One. 3:e0190815, 2018.

7. Paka P et al. A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease. World J Nephrol.;7:96-107, 2018.

8. Hwang A et al. Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH. PlosOne, 2018.

9. Patel SN et al. Kidney Appreciates Stable Blood Pressure. Am J Hypertens 31:532-533, 2018.

10. Dana D et al. Deep Learning in Drug Discovery and Medicine; Scratching the Surface. Molecules 23:E2384, 2018.

11. Narayan R. Mixed-Unit Lattice Approach for Area Determination of Cellular and Subcellular Structures. Appl Sci, 9, 5267, 2019.

12. Chavre BM et al. Remodeling of Intrahepatic Ducts in a Model of Caroli Syndrome: Is Scar Carcinoma a Consequence of Laplace's Law? Med Sci 7, 55, 2019.

13. Chao K et al. An Improved Method for Estimating Renal Dimensions; Implications for Management of Kidney Disease. Appl Sci 9:3198, 2019.

14. Narayan R et al. Collagen-driven remodeling of the intrahepatic duct wall in the PCK rat model of polycystic kidney disease-Caroli syndrome. Clin Exp Hepatol 6:131–136, 2020.

15. Jung L et al. Untangling the Potential of Carbon Quantum Dots in Neurodegenerative Disease. Processes 8:599, 2020.

16. Liao K et al. Glycerol-3-phosphate Acyltransferase1 Is a Model-Agnostic Node in Nonalcoholic Fatty Liver Disease: Implications for Drug Development and Precision Medicine. ACS Omega 5, 29:18465–18471, 2020.

17. Liu M et al. Targeting Collagen Type III in Proteinuric Kidney Disease: Informing Drug Potential Using the Jaccard–Tanimoto Index, Processes, 8:996, 2020.

18. Bissoondial TL et al. Liver Biopsy Hydroxyproline Content Is a Diagnostic for Hepatocellular Carcinoma in Murine Models of Nonalcoholic Steatohepatitis. Diagnostics. 10:784, 2020.

19. Pellicano AJ et al. Collagen Characterization in a Model of Nonalcoholic Steatohepatitis with Fibrosis; a Call for Development of Targeted Therapeutics, Molecules 26:3316, 2021.

20. Pellicano AJ et al. Hepatic mRNA Expression Levels of the Oncogenes Alpha-Fetoprotein and Osteopontin as Diagnostics for Liver Cancer in a Murine Model of Diet-Induced Non- alcoholic Steatohepatitis. Processes 9:1516, 2021.

21. Narayan R and Pellicano AJ. Machine learning on crowd-sourced data to highlight coral disease. JEI, 4, 2021.

22. Bissoondial TL et al. Identification of Disease-associated MicroRNA in a Diet-induced Model of Nonalcoholic Steatohepatitis. Royal Society of Chemistry, Mol. Omics, 2021. (Featured on Front Cover Page)

23. Bissoondial TL and Narayan P. Identification of a core set of model agnostic mRNA associated with Nonalcoholic

    Steatohepatitis (NASH). Journal of Emerging Investigators, JEI-21-262, 2022.